Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PepsiCo, Inc. (PEP) vs UnitedHealth Group Inc (UNH) Price & Performance

PepsiCo, Inc.Trade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

PepsiCo, Inc. vs UnitedHealth Group Inc — how do they compare? PepsiCo, Inc. trades at $137.12 (market cap $188.97B), while UnitedHealth Group Inc trades at $394.25 (market cap $359.79B). The key difference: UnitedHealth Group Inc is the larger of the two by market cap, and PepsiCo, Inc. pays the higher dividend (4.28%). Which is the better fit depends on your goals.

PEPUNH
Market Cap
$188.97B$359.79B
Sector
Consumer StaplesHealth
52-Week High
$170.44$436.35
52-Week Low
$134.95$259.02
Enterprise Value
$231.47B$401.65B
Dividend Yield
4.28%2.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PepsiCo, Inc.

PepsiCo (PEP) trades at $138.45, up 0.6% with bearish technical signals but strong fundamentals. The company reported consistent earnings beats in recent quarters with Q3 2026 results pending. Revenue grew to $93.93B in 2025, though net income declined to $8.24B. Analysts maintain a consensus price target of $158.79 with 33% buy ratings. Recent news highlights price adjustments on snack products and sponsorship changes.

PEP offers stable dividend income and moderate growth potential, but faces margin pressure from input costs and competitive pricing. The stock trades below analyst targets with solid cash flow generation, though technical indicators suggest near-term weakness. Key risks include consumer sensitivity to price increases and execution challenges in North American markets.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.

The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About PepsiCo, Inc.

PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.

Read more on PEP

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH